# Bioavailability of Hesperidine and Narirutin From Orange Juice to Identify Metabotypes in Hypertension

> **NCT04234100** · NA · COMPLETED · sponsor: **Technological Centre of Nutrition and Health, Spain** · enrollment: 67 (actual)

## Conditions studied

- Blood Pressure
- Hypertension

## Interventions

- **OTHER:** Orange juice rich in hesperidin and narirutin

## Key facts

- **NCT ID:** NCT04234100
- **Lead sponsor:** Technological Centre of Nutrition and Health, Spain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-24
- **Primary completion:** 2020-09-22
- **Final completion:** 2020-09-22
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04234100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04234100, "Bioavailability of Hesperidine and Narirutin From Orange Juice to Identify Metabotypes in Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04234100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*